CAREMED brings Spanish and Turkish healthcare partners together to exchange experiences on patient-centred care and chronic disease management following the APCM training in İzmir.
As part of the CAREMED – Community-based Approach for Resilient Mediterranean Health project, funded by the European Union through the Interreg NEXT MED Programme, representatives of Servei de Salut de les Illes Balears (Spain) met with the Assoc. Prof. Dr Ayhan Kul, Director and the management team of the İzmir Provincial Healthcare Directorate following the successful completion of the Active Patient Care Model (APCM) training held in İzmir.
The meeting represented an important opportunity to further strengthen cooperation between the Spanish and Turkish healthcare institutions involved in CAREMED and to exchange experiences on the prevention and management of non-communicable diseases (NCDs) in primary healthcare.
Interreg NEXT MED provides a unique platform for public institutions across the Mediterranean to work together, share expertise and transfer good practices. Within CAREMED, this cooperation enables partners to jointly develop, test and adapt innovative community-based care models that respond to the specific needs of their healthcare systems while benefiting from the experience of other Mediterranean countries.
Discussions focused on the implementation of the Active Patient Care Model, the role of primary healthcare in improving the management of chronic diseases, and the importance of patient empowerment and multidisciplinary collaboration. Participants also explored opportunities to further strengthen technical cooperation throughout the implementation of the project.
By bringing together healthcare professionals, public authorities and institutions from different countries, CAREMED continues to demonstrate how transnational cooperation can foster mutual learning, build institutional capacity and contribute to more resilient and patient-centred primary healthcare systems across the Mediterranean region.
Last Update
28/08/2026
Next Med